Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.

Publikation

Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.

Wissenschaftlicher Artikel/Review - 07.11.2022

Babouee Flury Baharak, Güsewell Sabine, Egger Thomas, Leal Onicio, Brucher Angela, Lemmenmeier Eva, Meier Kleeb Dorette, Möller J Carsten, Rieder Philip, Rütti Markus, Schmid Hans-Ruedi, Stocker Reto, Vuichard-Gysin Danielle, Wiggli Benedikt, Besold Ulrike, McGeer Allison, Risch Lorenz, Friedl Andree, Schlegel Matthias, Kuster Stefan, Kahlert Christian, Kohler Philipp, SURPRISE Study Group

Zitation

Babouee Flury B, Güsewell S, Egger T, Leal O, Brucher A, Lemmenmeier E, Meier Kleeb D, Möller J, Rieder P, Rütti M, Schmid H, Stocker R, Vuichard-Gysin D, Wiggli B, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Kuster S, Kahlert C, Kohler P, SURPRISE Study Group. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study. PLoS Med 2022; 19:e1004125.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

PLoS Med 2022; 19

Veröffentlichungsdatum

07.11.2022

eISSN (Online)

1549-1676

Seiten

e1004125

Kurzbeschreibung/Zielsetzung

Knowledge about protection conferred by previous Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and/or vaccination against emerging viral variants allows clinicians, epidemiologists, and health authorities to predict and reduce the future Coronavirus Disease 2019 (COVID-19) burden. We investigated the risk and symptoms of SARS-CoV-2 (re)infection and vaccine breakthrough infection during the Delta and Omicron waves, depending on baseline immune status and subsequent vaccinations.